Determinants of Blood Cell Omega-3 Fatty Acid Content - PubMed (original) (raw)
Determinants of Blood Cell Omega-3 Fatty Acid Content
Robert C Block et al. Open Biomark J. 2008.
Abstract
BACKGROUND: Although red blood cell eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) content (the Omega-3 Index) predicts cardiovascular death, the factors determining the Index are unknown. METHODS: In 704 outpatients, we undertook an investigation of the clinical determinants of the Index. RESULTS: Factors associated with the Index in decreasing order were: EPA+DHA supplement use, fish consumption frequency, triglyceride level, age, high cholesterol history, and smoking. These factors explained 59% of Index variability, with capsules/fish intake together accounting for 47%. The Index increased by 13% (p< 0.0001) for each serving level increase in fish intake and EPA+DHA supplementation correlated with a 58% increase (p< 0.0001) regardless of background fish intake (p=0.25; test for interaction). A 100 mg/dL decrease in serum triglycerides was associated with a 15% higher (p<0.0001) Index. CONCLUSIONS: The intake of EPA+DHA-rich foods and supplements principally determined the Omega-3 Index, but explained only about half of the variability.
Figures
Figure 1
Multiplier effects on the Omega-3 Index for all predictors included in the final multivariable log-normal regression model. The fish consumption estimates are compared to the reference of never eating fish. Data are presented as point estimates with 95% confidence intervals.
Figure 2
Raw data of the Omega-3 Index with 95% confidence intervals for each group with a combination of fish intake frequency and fish oil supplementation status, including group samples sizes.
Similar articles
- Cross-sectional study of the combined associations of dietary and supplemental eicosapentaenoic acid + docosahexaenoic acid on Omega-3 Index.
McDonnell SL, French CB, Baggerly CA, Harris WS. McDonnell SL, et al. Nutr Res. 2019 Nov;71:43-55. doi: 10.1016/j.nutres.2019.09.001. Epub 2019 Sep 11. Nutr Res. 2019. PMID: 31757628 - Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults.
Yang ZH, Amar M, Sampson M, Courville AB, Sorokin AV, Gordon SM, Aponte AM, Stagliano M, Playford MP, Fu YP, Yang S, Mehta NN, Remaley AT. Yang ZH, et al. Nutrients. 2020 Mar 12;12(3):749. doi: 10.3390/nu12030749. Nutrients. 2020. PMID: 32178279 Free PMC article. Clinical Trial. - A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T, Caso R, McMahon D, Nymark M. Hobbs T, et al. Altern Ther Health Med. 2014 Sep-Oct;20(5):18-23. Altern Ther Health Med. 2014. PMID: 25141367 Clinical Trial. - Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S, Arora RR, Singh M, Khosla S. Singh S, et al. Am J Ther. 2016 May-Jun;23(3):e905-10. doi: 10.1097/MJT.0000000000000165. Am J Ther. 2016. PMID: 25828517 Review. - Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
Holub BJ. Holub BJ. Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):199-204. doi: 10.1016/j.plefa.2009.05.016. Epub 2009 Jul 9. Prostaglandins Leukot Essent Fatty Acids. 2009. PMID: 19545988 Review.
Cited by
- Athletes Can Benefit from Increased Intake of EPA and DHA-Evaluating the Evidence.
Tomczyk M, Heileson JL, Babiarz M, Calder PC. Tomczyk M, et al. Nutrients. 2023 Nov 26;15(23):4925. doi: 10.3390/nu15234925. Nutrients. 2023. PMID: 38068783 Free PMC article. Review. - Dietary Intake, Biological Status, and Barriers towards Omega-3 Intake in Elite Level (Tier 4), Female Athletes: Pilot Study.
Hooks MP, Madigan SM, Woodside JV, Nugent AP. Hooks MP, et al. Nutrients. 2023 Jun 21;15(13):2821. doi: 10.3390/nu15132821. Nutrients. 2023. PMID: 37447148 Free PMC article. - Development and internal validation of a non-invasive clinical tool to predict sufficient omega-3 levels in early pregnancy.
Fu JY, Wang CA, Liu G, Mead E, Phung J, Makrides M, Pennell CE. Fu JY, et al. BMC Pregnancy Childbirth. 2023 Jun 14;23(1):442. doi: 10.1186/s12884-023-05687-2. BMC Pregnancy Childbirth. 2023. PMID: 37316786 Free PMC article. - Estimation and predictors of the Omega-3 Index in the UK Biobank.
Schuchardt JP, Tintle N, Westra J, Harris WS. Schuchardt JP, et al. Br J Nutr. 2023 Jul 28;130(2):312-322. doi: 10.1017/S0007114522003282. Epub 2022 Oct 10. Br J Nutr. 2023. PMID: 36210531 Free PMC article. - Association between systemic omega-3 polyunsaturated fatty acid levels, and corneal nerve structure and function.
Britten-Jones AC, Craig JP, Anderson AJ, Downie LE. Britten-Jones AC, et al. Eye (Lond). 2023 Jun;37(9):1866-1873. doi: 10.1038/s41433-022-02259-0. Epub 2022 Sep 26. Eye (Lond). 2023. PMID: 36163491 Free PMC article.
References
- Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113–8. - PubMed
- Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS. n-3 polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: The Cardiovascular Health Study. Am J Clin Nutr. 2003;77:319–25. - PubMed
- Harris WS, von Schacky The Omega-3 Index: a new risk factor for death from coronary heart disease? Preventive Medicine. 2004;39:212–20. - PubMed
- Leaf A, Kang JX, Xiao Y, Billman GE. Clinical prevention of sudden death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation. 2003;107:2646–52. - PubMed
- Kang JX, Leaf A. Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids. Am J Clin Nutr. 2000;71:202S–7S. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials